Abcellera Biologics Stock Target Price and Analyst Consensus
| ABCL Stock | USD 2.54 0.02 0.79% |
The current analyst and expert consensus on Abcellera Biologics is Strong Buy, with 6 strong buy opinions. The current projected Abcellera Biologics target price consensus is 12.14 with 9 analyst opinions. Check out Macroaxis Advice on Abcellera Biologics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.The most common way Abcellera Biologics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Abcellera Biologics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Abcellera Biologics. We strongly encourage you to use your own analysis of Abcellera Biologics to validate this buy or sell advice. Abcellera Biologics buy-or-sell recommendation module provides average expert sentiment on the projected Abcellera Biologics target price to derive its highest and lowest estimates based on projected price volatility of 4.6291.
Lowest Forecast 11.05 | Highest Forecast 13.48 | Target Price 12.14 |
Abcellera |
It's important to approach Abcellera Biologics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Abcellera Biologics Target Price Consensus
Abcellera target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Abcellera Biologics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 9 | Strong Buy |
Most Abcellera analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Abcellera stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Abcellera Biologics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationAbcellera Biologics Target Price Projection
Abcellera Biologics' current and average target prices are 2.54 and 12.14, respectively. The current price of Abcellera Biologics is the price at which Abcellera Biologics is currently trading. On the other hand, Abcellera Biologics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Abcellera Biologics Market Quote on 18th of March 2025
Target Price
Analyst Consensus On Abcellera Biologics Target Price
Abcellera Biologics Analyst Ratings
Abcellera Biologics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Abcellera Biologics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Abcellera Biologics' financials, market performance, and future outlook by experienced professionals. Abcellera Biologics' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Abcellera Biologics price targets
Abcellera Biologics' stock target price is an estimate of its future price, usually made by analysts. Using Abcellera Biologics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Abcellera Biologics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Abcellera Biologics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Abcellera Biologics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Abcellera Biologics is a key component of Abcellera Biologics valuation and have some predictive power on the future returns of a Abcellera Biologics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Abcellera Biologics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Business Services Invested few shares | |
 | Momentum Invested few shares | |
 | ESG Investing Invested few shares | |
 | Cash Cows Invested few shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Dividend Beast Invested over 60 shares | |
 | Social Domain Invested few shares | |
 | SRI Sustainable Growth Invested over 40 shares | |
 | Apparel Invested over 40 shares | |
 | Casinos Sold over 90 shares | |
 | Macroaxis Index Sold over 90 shares | |
 | Utilities Invested over 90 shares | |
Check out Macroaxis Advice on Abcellera Biologics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.